Ive had a great experience with S4L Plano location
Ascendis Pharma A/S granted Novo Nordisk A/S exclusive global rights to its TransCon technology for the development, manufacturing, and commercialisation of Novo Nordisk products aimed at metabolic diseases, including obesity and type 2 diabetes, along with select cardiovascular applications
Medical Disclaimer: This information is educational and not a substitute for medical advice
THE WIDELY used diabetes drug, semaglutide, may increase the risk of a rare but serious optic nerve condition, according to new research in US veterans, highlighting the need for careful counselling despite its proven cardiometabolic benefits
Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, et al
Receptor Response Maintenance: An important advantage of the cjc ipa blend is that it keeps receptor response better than constant GH use